Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ILF2 mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of ILF2 mRNA | decreases expression | 12958071
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of ILF2 mRNA | affects expression | 21346803
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of ILF2 mRNA | increases expression | 16474171
|
C099555 |
CD 437 |
CD 437 results in decreased expression of ILF2 mRNA | decreases expression | 12958071
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of ILF2 mRNA | increases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of ILF2 mRNA | increases expression | 16474171
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ILF2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ILF2 mRNA | affects cotreatment|increases expression | 17942748
|
D019833 |
Genistein |
Genistein results in increased expression of ILF2 mRNA | increases expression | 16474171
|
C027185 |
indirubin |
indirubin results in decreased expression of ILF2 mRNA | decreases expression | 15056799
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of ILF2 mRNA | increases expression | 16474171
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ILF2 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
9.00 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.00 | 14514962 15322242 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
7.22 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
7.22 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
7.22 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.97 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
1.97 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.97 | 16675129 17289903 17261762 14630087 17018787 12948864 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
1.97 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.62 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.70 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.70 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
4.70 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.14 | 17123778 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.38 | 16332659 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.69 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.82 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
6.82 | 18566989 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.05 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.05 | 16105132 11677210 17681005 17110522 16919318 17333356 15861022 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 15340226 12621046 8697196 15668235 16354765 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.30 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
2.73 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.52 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.52 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 10048152 20055451 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.15 | 18551238 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.81 | 16140633 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.41 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.41 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.51 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.43 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
6.43 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.43 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.84 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.74 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.74 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.74 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 10568697 9294722 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.95 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.95 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.95 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.95 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.37 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
3.33 | 16598420 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 11294989 10048152 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.58 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.21 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.93 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 8697196 15340226 18606429 16959395 16354765 |
MESH:D006968 |
Hypersensitivity, Delayed |
|
indirubin |
6.11 | 11275354 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.07 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.67 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.67 | 16393666 16627594 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.62 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.14 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
6.14 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.91 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.91 | 15610895 |
MESH:D007938 |
Leukemia |
|
Genistein |
3.07 | 18980019 17468513 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.54 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
3.54 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.54 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
6.34 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.34 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.31 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
6.31 | 14578162 12929590 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.66 | 19453300 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.96 | 16801185 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.90 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.80 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
8.80 | 17141266 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.01 | 18551238 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.89 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.62 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.38 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
24.56 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
24.56 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
24.56 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
24.56 | 14600291 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.48 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
9.48 | 14694615 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.32 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.20 | 16169203 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.14 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
CD 437 |
8.21 | 17474084 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.21 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
8.21 | 19005980 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
3.43 | 16702228 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.32 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
10.03 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.03 | 11896295 11222880 11118676 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
10.92 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
10.92 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.12 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.12 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.12 | 15378649 16925846 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.12 | 15721890 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.26 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.94 | 10548101 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.60 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.14 | 16684133 16045194 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.86 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.55 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
CD 437 |
5.55 | 16720286 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.47 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.18 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.16 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.62 | 17120751 |